NCT01163942
Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) treatment 3 terminated NCT01933035
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. No drug interventions Not Available Not Available completed NCT01224496
Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders No drug interventions supportive_care 1 / 2 completed NCT05031897
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant No drug interventions treatment 2 recruiting NCT06646497
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years No drug interventions treatment 2 not_yet_recruiting NCT05194397
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors No drug interventions treatment 2 recruiting NCT06633328
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia No drug interventions treatment 0 recruiting NCT06039020
ATGAM General Investigation No drug interventions Not Available Not Available active_not_recruiting NCT06398457
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies treatment 0 recruiting NCT06613880
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia treatment 2 not_yet_recruiting NCT00000603
Cord Blood Stem Cell Transplantation Study (COBLT) No drug interventions treatment 2 completed NCT00578903
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia treatment 2 terminated NCT04403321
Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients treatment 2 completed NCT00005302
Drug Etiology of Aplastic Anemia and Related Dyscrasias No drug interventions Not Available Not Available completed NCT03821987
Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA treatment Not Available unknown_status NCT06254287
Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA treatment 2 not_yet_recruiting NCT00881933
Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA) No drug interventions treatment 1 / 2 unknown_status NCT00011453
Protection Against Benzene Toxicity No drug interventions Not Available Not Available completed NCT00806598
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome treatment 2 completed NCT00001398
Stem Cell Factor Medication for Aplastic Anemia No drug interventions treatment 1 completed NCT05510505
GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT No drug interventions treatment 2 recruiting NCT00000597
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders treatment 3 completed NCT00186797
Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia treatment Not Available completed NCT00922883
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients treatment 2 completed NCT01500161
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match treatment 2 terminated NCT02007811
Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination No drug interventions treatment 1 / 2 unknown_status NCT02833493
Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload No drug interventions Not Available Not Available unknown_status NCT00399971
Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia No drug interventions treatment 1 / 2 unknown_status NCT03896971
Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia treatment 4 completed NCT03055078
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia No drug interventions treatment 1 unknown_status NCT03622788
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant treatment 1 / 2 recruiting NCT06430788
A Study of Emapalumab for Pediatric Aplastic Anemia treatment 2 recruiting NCT04819607
The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders. No drug interventions Not Available Not Available unknown_status NCT00636909
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders treatment 2 completed NCT02055456
Nandrolone Decanoate in the Treatment of Telomeropathies treatment 1 / 2 completed NCT00343785
Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant treatment 2 completed NCT00737685
Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA) treatment 2 unknown_status NCT05399732
Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia treatment 2 unknown_status NCT02462252
Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome treatment 2 completed NCT06004752
Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly treatment 2 recruiting NCT00006300
Oral Manifestations of Aplastic Anemia No drug interventions Not Available Not Available completed NCT00556400
Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones No drug interventions treatment 1 / 2 terminated NCT00975975
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer treatment 2 completed NCT00513175
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia No drug interventions Not Available Not Available completed NCT01408342
Alemtuzumab and Rituximab in Aplastic Anemia treatment Not Available withdrawn NCT01758042
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders No drug interventions treatment Not Available recruiting NCT04645199
National Longitudinal Cohort of Hematological Diseases No drug interventions Not Available Not Available recruiting NCT03016806
Umbilical Cord Blood Transplantation From Unrelated Donors treatment 1 recruiting NCT01659606
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita treatment 2 active_not_recruiting NCT00944749
Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment treatment 2 completed NCT05018936
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia treatment 2 / 3 unknown_status NCT01384513
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies treatment 2 completed NCT00354419
Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant treatment 1 terminated NCT01231841
Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia treatment 2 completed NCT01272817
Nonmyeloablative Allogeneic Transplant No drug interventions treatment Not Available completed NCT00326417
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) treatment 1 / 2 completed NCT05832216
Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients With Aplastic Anemia treatment 1 recruiting NCT02203396
A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia treatment 2 unknown_status NCT01760096
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) treatment 2 unknown_status NCT00005935
Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia treatment 2 completed NCT00997386
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States treatment 2 completed NCT04001686
Ambispective Observational Study to Evaluate the Incidence and Management of Aplastic Anemia in Spain No drug interventions Not Available Not Available unknown_status NCT03333486
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer treatment 2 active_not_recruiting NCT02404025
Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects treatment 2 completed NCT00471848
Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia treatment 2 completed NCT06525948
Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA treatment 4 not_yet_recruiting NCT03218657
Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole treatment Not Available unknown_status NCT00578266
Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia treatment 1 completed NCT06009965
Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System No drug interventions treatment 4 recruiting NCT04761965
Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy No drug interventions diagnostic Not Available recruiting NCT00005682
Aplastic Anemia Epidemiology: Incidence and Case-control No drug interventions Not Available Not Available completed NCT01995331
Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia treatment 4 unknown_status NCT04478227
TPO-Mimetic Use in Children for Hematopoietic Failure treatment 0 completed NCT01529827
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies treatment 2 completed NCT01199562
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Not Available Not Available completed NCT00001962
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure treatment 2 terminated NCT01182662
Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia No drug interventions treatment 2 unknown_status NCT00987480
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine treatment 2 completed NCT01343680
Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients prevention 3 terminated NCT00393380
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor prevention 2 terminated NCT04728789
Avatrombopag Usage in NSAA treatment 2 / 3 unknown_status NCT02838992
ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia treatment 4 unknown_status NCT01297972
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia No drug interventions treatment 1 / 2 completed NCT03301168
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant treatment 1 / 2 active_not_recruiting NCT06287268
Revolade Tablets Specified Drug-use Survey No drug interventions Not Available Not Available recruiting NCT02065869
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant treatment 1 / 2 terminated NCT04870346
Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia No drug interventions Not Available Not Available active_not_recruiting NCT00244010
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias No drug interventions treatment Not Available completed NCT00004323
Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia treatment 2 completed NCT03988608
Study to Assess the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. treatment 2 completed NCT01267643
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia treatment 1 terminated NCT02875743
King's Invasive Aspergillosis Study II prevention 4 completed NCT04128943
Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria No drug interventions Not Available Not Available completed NCT06491303
Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy No drug interventions Not Available Not Available not_yet_recruiting NCT02773290
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia treatment 2 / 3 completed NCT00004464
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria treatment 2 completed NCT05386264
Autologous Tregs for Aplastic Anaemia No drug interventions treatment 1 recruiting NCT06516484
Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study treatment 4 not_yet_recruiting NCT01642979
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria treatment 2 unknown_status NCT00038779
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States No drug interventions treatment Not Available terminated NCT00017654
Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia treatment Not Available unknown_status NCT06335277
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology No drug interventions Not Available Not Available recruiting NCT05972577
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study No drug interventions supportive_care Not Available active_not_recruiting NCT01499147
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies treatment Not Available completed NCT03208647
Multi Center Case Control Study on Multiple Risk Factors of Aplastic Anemia No drug interventions Not Available Not Available completed NCT02225145
Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease No drug interventions Not Available Not Available completed NCT01350245
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor treatment 2 completed NCT03025698
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia treatment 2 active_not_recruiting NCT02833805
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia treatment 2 completed NCT01624805
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome treatment 2 recruiting NCT01193283
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia treatment 1 / 2 completed NCT05333861
An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA Not Available Not Available not_yet_recruiting NCT05996393
CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly treatment 4 not_yet_recruiting NCT00319878
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia treatment 1 / 2 unknown_status NCT00856388
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders treatment Not Available completed NCT00005307
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data No drug interventions Not Available Not Available completed NCT04060485
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results No drug interventions Not Available Not Available recruiting NCT06535685
A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA treatment 4 not_yet_recruiting NCT01441037
Danazol for Genetic Bone Marrow and Lung Disorders treatment 1 / 2 completed NCT05571332
Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function treatment Not Available unknown_status NCT03086252
Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study No drug interventions supportive_care Not Available withdrawn NCT03318159
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients prevention 2 completed NCT00569842
Investigation of the Cylex® ImmuKnow® Assay No drug interventions Not Available Not Available completed NCT01956799
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy No drug interventions Not Available Not Available completed NCT00676806
A Phase II Study of Umbilical Cord Blood Transplantation treatment 2 terminated NCT04439006
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization treatment 1 completed NCT04350606
A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia treatment 3 completed NCT03176849
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT No drug interventions treatment 4 completed NCT03733249
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study treatment 1 / 2 terminated NCT04095936
Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia treatment 2 / 3 completed NCT04558736
Haploidentical HCT for Severe Aplastic Anemia treatment 2 recruiting NCT00427336
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia treatment Not Available completed NCT03906318
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia No drug interventions Not Available Not Available no_longer_available NCT00315419
Identifying Characteristics of Bone Marrow Failure Syndromes No drug interventions Not Available Not Available unknown_status NCT00229619
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia treatment 2 completed NCT01187017
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia treatment 1 / 2 completed NCT02094417
A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia treatment 2 completed NCT02028416
Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia treatment Not Available unknown_status NCT00061763
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias treatment 2 completed NCT06424639
Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA treatment 4 not_yet_recruiting NCT02773225
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) treatment 2 / 3 unknown_status NCT02857530
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia treatment 2 unknown_status NCT00011830
Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission treatment 1 completed NCT01241357
High-Tc Susceptometer to Monitor Transfusional Iron Overload No drug interventions Not Available Not Available completed NCT03373526
Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT00692926
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells No drug interventions treatment 1 completed NCT01818726
Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients treatment 4 terminated NCT01919866
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells No drug interventions treatment 1 / 2 unknown_status NCT00004474
Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia treatment 3 completed NCT02162420
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia treatment Not Available active_not_recruiting NCT01105273
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia treatment 1 / 2 completed NCT01145976
Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia treatment 3 unknown_status NCT00065260
Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia treatment 2 completed NCT01305694
Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. treatment 1 / 2 unknown_status NCT03957694
Study of AMG531(Romiplostim) in Patients With Aplastic Anemia treatment 2 / 3 completed NCT06004791
A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA treatment 4 not_yet_recruiting NCT00144729
Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor No drug interventions treatment 1 / 2 completed NCT00053989
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders treatment 2 completed NCT06518044
NAC for Hematopoietic Recovery in SAA treatment 2 not_yet_recruiting NCT02566304
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies treatment 2 active_not_recruiting NCT00618969
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors No drug interventions treatment 2 completed NCT00683046
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies treatment 2 completed NCT02960646
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies treatment 1 completed NCT00455312
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA treatment 2 / 3 completed NCT00673114
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies No drug interventions treatment 1 / 2 completed NCT01680055
Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their Receptors No drug interventions Not Available Not Available withdrawn NCT01760655
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies treatment 2 completed NCT00767650
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia No drug interventions Not Available Not Available completed NCT00533923
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders treatment 2 completed NCT00882323
Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA) treatment 2 unknown_status NCT06426043
A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag treatment 4 not_yet_recruiting NCT01861093
Safety Study of Cord Blood Units for Stem Cell Transplants No drug interventions treatment 2 recruiting NCT00474747
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia treatment 1 / 2 completed